Posted by Michael Wonder on 21 Jul 2020
TGA publishes AusPAR for Vemlidy
21 July 2020 - AusPAR published within days of its provisional registration; why do other take years?
Vemlidy was provisionally approved the TGA on 10 July 2020. An AusPAR for this outcome was published today (21 July 2020).
On 6 July 2020, the TGA published an AusPAR for the new biosimilar medicine Remsima/Emisima/Flixceli/Inflectra (infliximab). The TGA approved this medicine in August 2015. Why the five year delay?
